Key facts
- This page summarizes William F. Doyle's Form 4 filing for Elanco Animal Health Inc (ELAN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Dec 2024, 17:12.
William F. Doyle - 29 Nov 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)
- Reporting relationship
- Director
- Issuer ticker
- ELAN
- Reported as of
- 29 Nov 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2024, 17:12:25 UTC
- Prior SEC filing
- 03 Jun 2024
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy C. Seidel, as Attorney-in-Fact for William F. Doyle
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William F. Doyle filed Form 4 for Elanco Animal Health Inc (ELAN) on 03 Dec 2024.
Change
- Previous filing in this sequence was filed on 03 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELAN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +18,169
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 94,499
- Date
- 29 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.